Clear Search sequence regions


  • anion (1)
  • bafilomycin a1 (1)
  • BCL2 (2)
  • BNIP3 (8)
  • bnip3 protein, human (1)
  • BNIP3L (1)
  • cachexia (3)
  • calcium (1)
  • crc (1)
  • CTRL (1)
  • FUN14 (1)
  • FUNDC1 (1)
  • humans (1)
  • light (1)
  • MAP1LC3A (2)
  • mice (3)
  • mice knockout (1)
  • myoblast (1)
  • PGAM (1)
  • PGAM5 (8)
  • pgam5 protein, human (1)
  • phosphoprotein phosphatases (2)
  • protein human (2)
  • receptor (2)
  • represses (1)
  • s100 protein (1)
  • S100A9 (3)
  • skeletal muscle (4)
  • SQSTM1 (1)
  • TIMM23 (1)
  • TOMM20 (1)
  • VDAC1 (1)
  • weight loss (1)
  • Sizes of these terms reflect their relevance to your search.

    Regressing the accelerated degradation of skeletal muscle protein is a significant goal for cancer cachexia management. Here, we show that genetic deletion of Pgam5 ameliorates skeletal muscle atrophy in various tumor-bearing mice. pgam5 ablation represses excessive myoblast mitophagy and effectively suppresses mitochondria meltdown and muscle wastage. Next, we define BNIP3 as a mitophagy receptor constitutively associating with PGAM5. bnip3 deletion restricts body weight loss and enhances the gastrocnemius mass index in the age- and tumor size-matched experiments. The NH2-terminal region of PGAM5 binds to the PEST motif-containing region of BNIP3 to dampen the ubiquitination and degradation of BNIP3 to maintain continuous mitophagy. Finally, we identify S100A9 as a pro-cachectic chemokine via activating AGER/RAGE. AGER deficiency or S100A9 inhibition restrains skeletal muscle loss by weakening the interaction between PGAM5 and BNIP3. In conclusion, the AGER-PGAM5-BNIP3 axis is a novel but common pathway in cancer-associated muscle wasting that can be targetable. Abbreviation: AGER/RAGE: advanced glycation end-product specific receptor; BA1: bafilomycin A1; BNIP3: BCL2 interacting protein 3; BNIP3L: BCL2 interacting protein 3 like; Ckm-Cre: creatinine kinase, muscle-specific Cre; CM: conditioned medium; CON/CTRL: control; CRC: colorectal cancer; FUNDC1: FUN14 domain containing 1; MAP1LC3A/LC3A: microtubule associated protein 1 light chain 3 alpha; PGAM5: PGAM family member 5, mitochondrial serine/threonine protein phosphatase; S100A9: S100 calcium binding protein A9; SQSTM1/p62: sequestosome 1; TOMM20: translocase of outer mitochondrial membrane 20; TIMM23: translocase of inner mitochondrial membrane 23; TSKO: tissue-specific knockout; VDAC1: voltage dependent anion channel 1.

    Citation

    Qingyuan Zhang, Chunhui Chen, Ye Ma, Xinyi Yan, Nianhong Lai, Hao Wang, Baogui Gao, Anna Meilin Gu, Qinrui Han, Qingling Zhang, Lei La, Xuegang Sun. PGAM5 interacts with and maintains BNIP3 to license cancer-associated muscle wasting. Autophagy. 2024 Oct;20(10):2205-2220

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38919131

    View Full Text